Root Financial Partners’s Pacira BioSciences PCRX Stock Holding History

Root Financial Partners’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16	Closed	-$362	–	2366
2026 Q1	$362	Buy	+16	New	+$356	﹤0.01%	2975

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Root Financial Partners's PCRX Position: Q2 2026 in Review

Root Financial Partners sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 16 shares — an estimated $362 sold.

Root Financial Partners first reported a position in PCRX in Q1 2026 and held it in 1 quarter. The position peaked at $362 in Q1 2026. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Root Financial Partners reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 16 Pacira BioSciences shares in Q2 2026, an estimated $362.
Root Financial Partners first reported a position in Pacira BioSciences in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Pacira BioSciences position peaked at $362 in Q1 2026.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.